NIH-funded research Sbir 2 grant

Daily localized ultrasound patch to deliver NSAID for knee osteoarthritis

Official title: Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis

Funded at Zetroz Systems, LLC · NIH-11194246 · Data updated 2026-11-12

A daily wearable ultrasound patch that pushes an NSAID into the knee to help reduce pain for adults with knee osteoarthritis.

More Osteoarthritis research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionZetroz Systems, LLC
NIH-funded
Lab location1 site (Trumbull, United States)
Project startSeptember 20, 2024
Project endMay 31, 2027
Funding year2025
Award (this year)$2,359,304
NIH project number5R44AG061985-07
Project IDNIH-11194246 on NIH RePORTER

Who could benefit from this research

Could help

Adults with symptomatic knee osteoarthritis (age 21+, especially people 65 and older) who have chronic knee pain and want a localized non-oral treatment option.

Less likely to help

People with a known allergy to NSAIDs/diclofenac, active skin infection or open wounds at application sites, inflammatory arthritides like rheumatoid arthritis, or medical conditions that preclude topical NSAID or ultrasound use may not benefit.

What this research studies

You would wear a daily ultrasound patch that uses sonophoresis to drive diclofenac, a common NSAID, deeper into your knee to relieve osteoarthritis pain. The device combines long-duration ultrasound with a topical diclofenac reservoir so the medicine reaches joint tissues while limiting how much enters your bloodstream. The team has already developed a Phase I/II prototype and will refine the patch and measure pain relief, joint function, and skin reactions in people with knee OA. If it works, the patch could offer localized pain control without the systemic risks of oral NSAIDs or frequent steroid injections.

Why it matters

Potential benefit: Could reduce knee pain and improve mobility by delivering NSAID directly to the joint while lowering systemic side effects.

How similar studies have gone: Prior studies of long-duration ultrasound and sonophoresis with topical NSAIDs have shown pain and function improvements, and the team's Phase I/II prototype produced encouraging results.

Where this research is happening

  • Zetroz Systems, LLC
    Trumbull, United States
    Active

Researchers

  • Principal investigator: Lewis, George Kenneth — Zetroz Systems, LLC
  • Study coordinator: Lewis, George Kenneth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.